Literature DB >> 26607823

Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.

Hasret Ayyıldız1, Şenol Turan2, Didem Gülcü1, Cana Aksoy Poyraz3, Esra Pehlivanoğlu1, Fügen Çullu1, Mehmet Kemal Arıkan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26607823     DOI： 10.1007/s40519-015-0247-3

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN： 1124-4909            Impact factor:   4.652


× No keyword cloud information.
  3 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  Jeffrey R Strawn; Paul E Keck; Stanley N Caroff
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

2.  Second generation antipsychotics in adolescent anorexia nervosa: a new hypothesis of eligibility criteria.

Authors:  Simone Pisano; Gennaro Catone; Antonio Pascotto; Antonella Gritti
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-14       Impact factor: 2.576

3.  Atypical neuroleptic malignant syndrome caused by olanzapine.

Authors:  J Nielsen; A M Bruhn
Journal:  Acta Psychiatr Scand       Date:  2005-09       Impact factor: 6.392
  3 in total
  2 in total

Review 1.  Canadian practice guidelines for the treatment of children and adolescents with eating disorders.

Authors:  Jennifer Couturier; Leanna Isserlin; Mark Norris; Wendy Spettigue; Melissa Brouwers; Melissa Kimber; Gail McVey; Cheryl Webb; Sheri Findlay; Neera Bhatnagar; Natasha Snelgrove; Amanda Ritsma; Wendy Preskow; Catherine Miller; Jennifer Coelho; Ahmed Boachie; Cathleen Steinegger; Rachel Loewen; Techiya Loewen; Elizabeth Waite; Catherine Ford; Kerry Bourret; Joanne Gusella; Josie Geller; Adele LaFrance; Anick LeClerc; Jennifer Scarborough; Seena Grewal; Monique Jericho; Gina Dimitropoulos; David Pilon
Journal:  J Eat Disord       Date:  2020-02-01

2.  Neuroleptic malignant syndrome in a patient with stable dose of olanzapine.

Authors:  Manoj Kumar Sahoo; Sangita Kamath; Abhijeet Sharan
Journal:  J Family Med Prim Care       Date:  2017 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.